Extensive research has unveiled the ability of HDAC6-inhibition to halt protein degradation, leading to significant accumulation of polyubiquitinated proteins by targeting the aggresomal protein degradation machinery; thus ultimately favoring MM cell apoptosis. Here, HDAC6 is linked to Miyoshi myopathy.